Venue-Based HIV Testing at Sex Work Hotspots to Reach Adolescent Girls and Young Women Living With HIV: A Cross-sectional Study in Mombasa, Kenya.
Journal
Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005
Informations de publication
Date de publication:
15 08 2020
15 08 2020
Historique:
entrez:
22
7
2020
pubmed:
22
7
2020
medline:
12
3
2021
Statut:
ppublish
Résumé
We estimated the potential number of newly diagnosed HIV infections among adolescent girls and young women (AGYW) using a venue-based approach to HIV testing at sex work hotspots. We used hotspot enumeration and cross-sectional biobehavioral survey data from the 2015 Transition Study of AGYW aged 14-24 years who frequented hotspots in Mombasa, Kenya. We described the HIV cascade among young females who sell sex (YFSS) (N = 408) versus those young females who do not sell sex (YFNS) (N = 891) and triangulated the potential (100% test acceptance and accuracy) and feasible (accounting for test acceptance and sensitivity) number of AGYW that could be newly diagnosed through hotspot-based HIV rapid testing in Mombasa. We identified the profile of AGYW with an HIV in the past year using generalized linear mixed regression models. N = 37/365 (10.1%) YFSS and N = 30/828 (3.6%) YFNS were living with HIV, of whom 27.0% (N = 10/37) and 30.0% (N = 9/30) were diagnosed and aware (P = 0.79). Rapid test acceptance was 89.3%, and sensitivity was 80.4%. There were an estimated 15,635 (range: 12,172-19,097) AGYW at hotspots. The potential and feasible number of new diagnosis was 627 (310-1081), and 450 (223-776), respectively. Thus, hotspot-based testing could feasibly reduce the undiagnosed fraction from 71.6% to 20.2%. The profile of AGYW who recently tested was similar among YFSS and YFNS. YFSS were 2-fold more likely to report a recent HIV test after adjusting for other determinants [odds ratio (95% confidence interval): 2.2 (1.5 to 3.1)]. Reaching AGYW through hotspot-based HIV testing could fill gaps left by traditional, clinic-based HIV testing services.
Sections du résumé
BACKGROUND
We estimated the potential number of newly diagnosed HIV infections among adolescent girls and young women (AGYW) using a venue-based approach to HIV testing at sex work hotspots.
METHODS
We used hotspot enumeration and cross-sectional biobehavioral survey data from the 2015 Transition Study of AGYW aged 14-24 years who frequented hotspots in Mombasa, Kenya. We described the HIV cascade among young females who sell sex (YFSS) (N = 408) versus those young females who do not sell sex (YFNS) (N = 891) and triangulated the potential (100% test acceptance and accuracy) and feasible (accounting for test acceptance and sensitivity) number of AGYW that could be newly diagnosed through hotspot-based HIV rapid testing in Mombasa. We identified the profile of AGYW with an HIV in the past year using generalized linear mixed regression models.
RESULTS
N = 37/365 (10.1%) YFSS and N = 30/828 (3.6%) YFNS were living with HIV, of whom 27.0% (N = 10/37) and 30.0% (N = 9/30) were diagnosed and aware (P = 0.79). Rapid test acceptance was 89.3%, and sensitivity was 80.4%. There were an estimated 15,635 (range: 12,172-19,097) AGYW at hotspots. The potential and feasible number of new diagnosis was 627 (310-1081), and 450 (223-776), respectively. Thus, hotspot-based testing could feasibly reduce the undiagnosed fraction from 71.6% to 20.2%. The profile of AGYW who recently tested was similar among YFSS and YFNS. YFSS were 2-fold more likely to report a recent HIV test after adjusting for other determinants [odds ratio (95% confidence interval): 2.2 (1.5 to 3.1)].
CONCLUSION
Reaching AGYW through hotspot-based HIV testing could fill gaps left by traditional, clinic-based HIV testing services.
Identifiants
pubmed: 32692105
doi: 10.1097/QAI.0000000000002363
pii: 00126334-202008150-00005
pmc: PMC7340222
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
470-479Subventions
Organisme : CIHR
ID : MOP-13044
Pays : Canada
Organisme : CIHR
ID : FDN 13455
Pays : Canada
Références
PLoS One. 2018 May 31;13(5):e0197479
pubmed: 29851988
J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):296-304
pubmed: 30113403
Pediatr Res. 2016 Jun;79(6):838-45
pubmed: 26882367
PLoS Med. 2017 Jul 25;14(7):e1002361
pubmed: 28742800
PLoS One. 2018 Sep 19;13(9):e0203784
pubmed: 30231072
BMC Public Health. 2011 Sep 03;11:685
pubmed: 21888666
PLoS One. 2018 Nov 1;13(11):e0205056
pubmed: 30383786
AIDS Care. 2014;26(12):1619-24
pubmed: 25040114
J Int AIDS Soc. 2015 Feb 26;18(2 Suppl 1):19833
pubmed: 25724511
J Acquir Immune Defic Syndr. 2010 Jul;54(3):317-23
pubmed: 20453819
Trop Med Int Health. 2016 Oct;21(10):1293-1303
pubmed: 27479236
Lancet Infect Dis. 2011 Jul;11(7):525-32
pubmed: 21546309
J Int AIDS Soc. 2018 Jul;21 Suppl 5:e25132
pubmed: 30033589
Infect Dis Poverty. 2016 Sep 06;5(1):92
pubmed: 27595846
J Int AIDS Soc. 2019 Jul;22 Suppl 4:e25311
pubmed: 31328436
PLoS One. 2019 Sep 26;14(9):e0221906
pubmed: 31557176
JMIR Public Health Surveill. 2019 Apr 01;5(2):e11196
pubmed: 30932868
Epidemics. 2018 Jun;23:34-41
pubmed: 29223580
AIDS. 2017 Jul 1;31 Suppl 3:S191-S194
pubmed: 28665876
Curr Opin HIV AIDS. 2018 May;13(3):257-264
pubmed: 29401121
AIDS Care. 2017 Nov;29(11):1364-1372
pubmed: 28325068
BMC Public Health. 2019 Jan 5;19(1):15
pubmed: 30611219
J Int AIDS Soc. 2017 Aug 29;20(Suppl 6):21755
pubmed: 28872271
Afr Health Sci. 2013 Dec;13(4):1012-20
pubmed: 24940326
Adolesc Health Med Ther. 2018 Dec 04;9:211-235
pubmed: 30584383
Stud Fam Plann. 2013 Jun;44(2):169-87
pubmed: 23720001
PLoS One. 2018 Apr 5;13(4):e0195391
pubmed: 29621308
JMIR Res Protoc. 2017 Dec 13;6(12):e179
pubmed: 29237583
AIDS Behav. 2019 Sep;23(Suppl 2):183-193
pubmed: 31134462